Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter

J Clin Endocrinol Metab. 2003 Dec;88(12):6113-4; author reply 6114-5. doi: 10.1210/jc.2003-031358.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Dose-Response Relationship, Radiation
  • Goiter, Nodular / drug therapy*
  • Goiter, Nodular / radiotherapy*
  • Humans
  • Iodine Radioisotopes / administration & dosage*
  • Premedication*
  • Recombinant Proteins / therapeutic use
  • Thyrotropin / therapeutic use*

Substances

  • Iodine Radioisotopes
  • Recombinant Proteins
  • Thyrotropin